Resistance to IFN-α-induced apoptosis is linked to a loss of STAT2

Molecular Cancer Research

Volumn 8, Issue 1, 2010, Pages 80-92

  Romero Weaver, Ana L ^a   Wang, Hsiang Wen ^a   Steen, Håkan C ^b   Scarzello, Anthony J ^a   Hall, Veronica L ^a   Sheikh, Faruk ^c   Donnelly, Raymond P ^c   Gamero, Ana M ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; STAT2 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TYROSINE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSOL; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

APOPTOSIS; CELL NUCLEUS; DRUG RESISTANCE, NEOPLASM; GENE DELETION; GENE SILENCING; HUMANS; INTERFERON-ALPHA; JURKAT CELLS; MITOCHONDRIA; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; STAT2 TRANSCRIPTION FACTOR; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 75149140545     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0344     Document Type: Article

References (44)

1. Guilhot F, Roy L, Guilhot J, Millot F. Interferon therapy in chronic myelogenous leukemia. Hematol Oncol Clin North Am 2004;18:585-603, viii.
2. Bleumer I, Oosterwijk E, De Mulder P, Mulders PF. Immunotherapy for renal cell carcinoma. Eur Urol 2003;44:65-75.
3. Stoutenburg JP, Schrope B, Kaufman HL. Adjuvant therapy for malignant melanoma. Expert Rev Anticancer Ther 2004;4:823-35.
4. Brunetto MR, Bonino F. Treatment of chronic hepatitis B: from research to clinical practice via the consensus conferences. Curr Pharm Des 2004;10:2063-75.
5. Picardi A, Gentilucci UV, Zardi EM, D'Avola D, Amoroso A, Afeltra A. The role of ribavirin in the combination therapy of hepatitis C virus infection. Curr Pharm Des 2004;10:2081-92.
6. Burks J. Interferon-β1b for multiple sclerosis. Expert Rev Neurother 2005;5:153-64.
7. Kantarjian HM, O'Brien S, Anderlini P, Talpaz M. Treatment of myelogenous leukemia: current status and investigational options. Blood 1996;87:3069-81.
8. Li Z, Metze D, Nashan D, et al. Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma. J Investig Dermatol 2004; 123:737-45.
9. Ruuth K, Berglund A, Munoz V, Lundgren E. Differential resistance of melanoma cells to treatment with recombinant IFN-a2b and leukocyte IFN. Anticancer Res 2007;27:2109-14.
10. Nyingi Kemmer GWN. Managing chronic hepatitis C in the difficult-to-treat patient. 2007:1297-310.
11. Wong LH, Krauer KG, Hatzinisiriou I, et al. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-3γ. J Biol Chem 1997;272:28779-85.
12. Dunn GP, Sheehan KC, Old LJ, Schreiber RD. IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression. Cancer Res 2005;65:3447-53.
13. Wellbrock C, Weisser C, Hassel JC, et al. STAT5 contributes to interferon resistance of melanoma cells. Curr Biol 2005;15:1629-39.
14. Ambrus JL, Sr., Dembinski W, Ambrus JL, Jr., et al. Free interferon-α/β receptors in the circulation of patients with adenocarcinoma. Cancer 2003;98:2730-3.
15. Reu FJ, Bae SI, Cherkassky L, et al. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation. J Clin Oncol 2006;24:3771-9.
16. Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004;202:8-32.
17. Decker T, Lew DJ, Mirkovitch J, Darnell JE, Jr. Cytoplasmic activation of GAF, an IFN-γ-regulated DNA-binding factor. EMBO J 1991; 10:927-32.
18. Kessler DS, Veals SA, Fu X-Y, Levy DS. Interferon-a regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev 1990;4:1753-65.
19. Leung S, Qureshi SA, Kerr IM, Darnell JE, Jr., Stark GR. Role of STAT2 in the α interferon signaling pathway. Mol Cell Biol 1995;15: 1312-7.
20. Rawlings JS, Rosler KM, Harrison DA. The JAK/STAT signaling pathway. J Cell Sci 2004;117:1281-3.
21. Qureshi SA, Leung S, Kerr IM, Stark GR, Darnell JE, Jr. Function of Stat2 protein in transcriptional activation by α interferon. Mol Cell Biol 1996;16:288-93.
22. Gamero AM, Larner AC. Vanadate facilitates interferon α-mediated apoptosis that is dependent on the Jak/Stat pathway. J Biol Chem 2001;276:13547-53.
23. Gimeno R, Lee CK, Schindler C, Levy DE. Stat1 and stat2 but not stat3 arbitrate contradictory growth signals elicited by α/β interferon in T lymphocytes. Mol Cell Biol 2005;25:5456-65.
24. Park C, Li S, Cha E, Schindler C. Immune response in Stat2 knockout mice. Immunity 2000;13:795-804.
25. Wang J, Pham-Mitchell N, Schindler C, Campbell IL. Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-α-stimulated STAT2-independent production of IFN-γ in the brain. J Clin Invest 2003;112:535-43.
26. Gamero AM, Sakamoto S, Montenegro J, Larner AC. Identification of a novel conserved motif in the STAT family that is required for tyrosine phosphorylation. J Biol Chem 2004;279:12379-85.
27. Scarzello AJ, Romero-Weaver AL, Maher SG, et al. A mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosis. Mol Biol Cell 2007;18: 2455-62.
28. Gamero AM, Potla R, Sakamoto S, Baker DP, Abraham R, Larner AC. Type I interferons activate apoptosis in a Jurkat cell variant by caspase-dependent and independent mechanisms. Cell Signal 2006;18: 1299-308.
29. Sangfelt O, Erickson S, Castro J, Heiden T, Einhorn S, Grander D. Induction of apoptosis and inhibition of cell growth are independent responses to interferon-α in hematopoietic cell lines. Cell Growth Differ 1997;8:343-52.
30. Hobart M, Ramassar V, Goes N, Urmson J, Halloran PF. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J Immunol 1997; 158:4260-9.
31. Massa PT, Whitney LW, Wu C, Ropka SL, Jarosinski KW. A mechanism for selective induction of 2′-5′ oligoadenylate synthetase, antiviral state, but not MHC class I genes by interferon-β in neurons. J Neurovirol 1999;5:161-71.
32. Li X, Leung S, Qureshi S, Darnell JE, Jr., Stark GR. Formation of STAT1-2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-α. J Biol Chem 1996;271: 5790-4.
33. Melen K, Kinnunen L, Julkunen I. Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs. J Biol Chem 2001;276:16447-55.
34. Chawla-Sarkar M, Leaman DW, Jacobs BS, et al. Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1). J Interferon Cytokine Res 2002;22:603-13.
35. Lesinski GB, Valentino D, Hade EM, et al. Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-α adjuvant therapy. Cancer Immunol Immunother 2005;54: 815-25.
36. Zhou Y, Wang S, Gobl A, Oberg K. Interferon α induction of Stat1 and Stat2 and their prognostic significance in carcinoid tumors. Oncology 2001;60:330-8.
37. Mischiati C, Natali PG, Sereni A, et al. cDNA-array profiling of melanomas and paired melanocyte cultures. J Cell Physiol 2006;207: 697-705.
38. Sanceau J, Hiscott J, Delattre O, Wietzerbin J. IFN-βinduces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7. Oncogene 2000;19:3372-83.
39. Zhao W, Cha EN, Lee C, Park CY, Schindler C. Stat2-dependent regulation of MHC class II expression. J Immunol 2007;179:463-71.
40. Hartman SE, Bertone P, Nath AK, et al. Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev 2005;19:2953-68.
41. Chawla-Sarkar M, Lindner DJ, Liu YF, et al. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003;8:237-49.
42. Panaretakis T, Pokrovskaja K, Shoshan MC, Grander D. Interferon-α- induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax. Oncogene 2003; 22:4543-56.
43. Thyrell L, Hjortsberg L, Arulampalam V, et al. Interferon α-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway. J Biol Chem 2004;279:24152-62.
44. Panaretakis T, Hjortsberg L, Tamm KP, Bjorklund A-C, Joseph B, Grander D. Interferon {α} Induces nucleus-independent apoptosis by activating extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase downstream of phosphatidylinositol 3-kinase and mammalian target of rapamycin. Mol Biol Cell 2008;19: 41-50.